WHAT IS KOSELUGO?
Koselugo is the FIRST and ONLY FDA-approved treatment shown to reduce the size of plexiform neurofibromas (PN)*
Do you have questions about Koselugo?
Talk to your child's doctor and download our FAQs
CAN KOSELUGO HELP SHRINK PLEXIFORM TUMORS?
KOSELUGO HAS BEEN SHOWN TO SHRINK PLEXIFORM TUMORS IN CHILDREN AGED 2 YEARS AND OLDER
In a clinical study, Koselugo was proven to work for children with NF1 who have plexiform neurofibromas (PN) that cannot be completely removed by surgery:
66% or 33 of 50 patients in the clinical study saw their plexiform neurofibromas (PN) shrink*
82% or 27 of 33 patients who responded continued to benefit for at least one year.
What did people taking Koselugo treatment experience in a clinical study? Learn more
*Patients saw a 20% or more decrease in the size of their plexiform neurofibromas, confirmed by 3D magnetic resonance imaging scan.
NF1=neurofibromatosis type 1.
IS THERE A SUPPORT PROGRAM TO HELP MY CHILD ACCESS TREATMENT?
OneSource™ Support Services
Your dedicated Patient Access Navigator is here to guide and give you the support you deserve—whatever your care plan may be. They can:
- Answer questions about neurofibromatosis type 1 (NF1) plexiform neurofibromas (PN), Koselugo, your insurance coverage, and more
- Provide support during treatment
- Help you avoid interruptions in your child’s treatment during insurance changes, travel plans, or other life events
- Help you to get involved with the rare disease community through events and meetings
To learn more or to contact your dedicated Patient Access Navigator, please call 1-888-765-4747, Monday through Friday, 8:30 AM–8 PM ET, or visit www.AlexionOneSource.com.